Published in Int Ophthalmol on April 20, 2010
Determinants of extraocular muscle volume in patients with graves' disease. J Thyroid Res (2012) 0.76
Thyroid-associated Ophthalmopathy. Turk J Ophthalmol (2017) 0.75
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med (1998) 3.98
Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med (1992) 3.86
Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev (1993) 2.23
Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev (2000) 2.06
Classification of eye changes of Graves' disease. Thyroid (1992) 1.66
Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism. Thyroid (1998) 1.45
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience. Eur J Endocrinol (2003) 1.29
Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med (1998) 1.28
Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol (2006) 1.19
Ten year results of I-131 therapy of hyperthyroidism. Bull N Y Acad Med (1957) 1.11
The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole. J Clin Endocrinol Metab (1994) 1.06
Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab (1995) 1.04
Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol (1994) 1.02
Treatment of Graves' disease and the course of ophthalmopathy. Am J Med (1989) 0.97
Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres. Eur J Endocrinol (2002) 0.92
The measurement of change in Graves' ophthalmopathy. Thyroid (1998) 0.91
A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy. J Clin Endocrinol Metab (2005) 0.88
Preventing Graves' ophthalmopathy. N Engl J Med (1998) 0.84
Comparison of RA 131I treatment protocols for Graves' disease. J Endocrinol Invest (1990) 0.82
Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy. J Clin Endocrinol Metab (1995) 0.77
Ophthalmopathy and hyperthyroidism. A comparison between patients receiving different antithyroid treatments. Acta Ophthalmol (Copenh) (1986) 0.76
Therapy for hyperthyroidism and Graves' ophthalmopathy. N Engl J Med (1998) 0.75
A prospective study of the differential changes in serum thyroglobulin and its autoantibodies during propylthiouracil or radioiodine therapy of patients with Graves' disease. Acta Endocrinol (Copenh) (1982) 0.75
Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine. J Endocrinol Invest (1991) 0.75
Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA (2010) 11.59
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry (2010) 2.99
Is high dose vitamin D harmful? Calcif Tissue Int (2012) 2.43
Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet (2011) 2.34
Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Bone (2006) 1.81
Vildagliptin-induced acute pancreatitis. Endocr Pract (2011) 1.77
Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med (2002) 1.71
Leptin inhibits osteoclast generation. J Bone Miner Res (2002) 1.64
Outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australian case series. Med J Aust (2007) 1.56
WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet (2012) 1.55
Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis (2007) 1.53
Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study. J Bone Miner Res (2004) 1.50
Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture. Menopause (2013) 1.47
Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res (2004) 1.44
Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry (2010) 1.35
The human cost of fracture. Osteoporos Int (2005) 1.33
Tobacco smoking as a risk factor for major depressive disorder: population-based study. Br J Psychiatry (2008) 1.31
Prevalence of obesity and the relationship between the body mass index and body fat: cross-sectional, population-based data. PLoS One (2012) 1.29
Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study. Endocrine (2011) 1.29
Conversion to Graves' hyperthyroidism in a patient with hypothyroidism due to Hashimoto's thyroiditis documented by real-time thyroid ultrasonography. Thyroid (2008) 1.23
Behavioural and physical characteristics associated with vitamin D status in women. Bone (2009) 1.18
Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet (2013) 1.17
Magnetic resonance imaging study in older fragile X premutation male carriers. Ann Neurol (2005) 1.16
Socioeconomic status and risk factors for obesity and metabolic disorders in a population-based sample of adult females. Prev Med (2009) 1.12
A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. BMC Med (2013) 1.11
Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res (2006) 1.10
Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol (2008) 1.09
Mycobacterium ulcerans infection: factors influencing diagnostic delay. Med J Aust (2007) 1.09
Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom (2010) 1.07
Stress and thyroid autoimmunity. Thyroid (2004) 1.07
High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA (2006) 1.07
Eye and eyelid abnormalities are common in patients with Hashimoto's thyroiditis. Thyroid (2010) 1.06
Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) (2007) 1.06
Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women. J Womens Health (Larchmt) (2006) 1.04
Trials and tribulations of recruiting 2,000 older women onto a clinical trial investigating falls and fractures: Vital D study. BMC Med Res Methodol (2009) 1.03
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02
Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry (2012) 1.01
Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study. J Affect Disord (2007) 1.01
Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterol (2010) 1.01
Lifetime psychiatric disorders and body composition: a population-based study. J Affect Disord (2009) 1.00
Habitual physical activity and the risk for depressive and anxiety disorders among older men and women. Int Psychogeriatr (2010) 0.98
Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology (2011) 0.97
General medical practitioners' knowledge and beliefs about osteoporosis and its investigation and management. Arch Osteoporos (2012) 0.96
Osteoclastic potential of human CFU-GM: biphasic effect of GM-CSF. J Bone Miner Res (2003) 0.96
BMD in population-based adult women is associated with socioeconomic status. J Bone Miner Res (2009) 0.96
Prevalence of osteoporosis in Australian men and women: Geelong Osteoporosis Study. Med J Aust (2011) 0.96
Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role? Clin Ophthalmol (2010) 0.95
Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis. Thyroid (2007) 0.95
Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study. Menopause (2005) 0.94
M-CSF potently augments RANKL-induced resorption activation in mature human osteoclasts. PLoS One (2011) 0.94
Does an increase in body mass index over 10 years affect knee structure in a population-based cohort study of adult women? Arthritis Res Ther (2010) 0.93
Diet quality in bipolar disorder in a population-based sample of women. J Affect Disord (2011) 0.93
Current concepts in graves' disease. Ther Adv Endocrinol Metab (2011) 0.91
Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy. Clin Ophthalmol (2012) 0.88
The association between depressive and anxiety symptoms and bone mineral density in the general population: the HUNT Study. J Affect Disord (2011) 0.88
Annual feedback is an effective tool for a sustained increase in calcium intake among older women. Nutrients (2010) 0.87
Multiple roles of M-CSF in human osteoclastogenesis. J Cell Biochem (2007) 0.87
Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy. Clin Endocrinol (Oxf) (2003) 0.86
Depression and bone metabolism. A review. Psychother Psychosom (2008) 0.86
Acute delirium in the setting of primary hypothyroidism: the role of thyroid hormone replacement therapy. Thyroid (2005) 0.86
Dietary selenium and major depression: a nested case-control study. Complement Ther Med (2012) 0.86
The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event. Clin Endocrinol (Oxf) (2010) 0.85
Depression following fracture in women: a study of age-matched cohorts. BMJ Open (2014) 0.85
Cross-sectional analysis of association between socioeconomic status and utilization of primary total hip joint replacements 2006-7: Australian Orthopaedic Association National Joint Replacement Registry. BMC Musculoskelet Disord (2012) 0.85
Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation in mesenchymal stem cells in a glycoprotein-130 dependent manner. PLoS One (2013) 0.84
Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults. Maturitas (2013) 0.84
Beta-blockers reduce bone resorption marker in early postmenopausal women. Ann Hum Biol (2006) 0.84
Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: a pilot study. Transl Res (2007) 0.84
Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease? Orbit (2009) 0.84
Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro. J Cell Biochem (2004) 0.83
Paracetamol (acetaminophen) use, fracture and bone mineral density. Bone (2011) 0.83
Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction. Ocul Immunol Inflamm (2007) 0.83
Total and appendicular lean mass reference ranges for Australian men and women: the Geelong osteoporosis study. Calcif Tissue Int (2014) 0.83
Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor. Autoimmunity (2002) 0.83